Executive Director, Children’s Cancer Therapy Development Institute (Beaverton, OR) Join the team of “rebel scientists” at cc-TDI who are pushing the boundaries of scientific innovation
The Children’s Cancer Therapy Development Institute (cc-TDI) was awarded $100,000 in support of Diffuse Intrinsic Pontine Glioma (DIPG) research by The Lyla Nsouli Foundation for
My name is Amy, and I am the proud mom of two amazing boys, Avery and Evan. Our son Avery has battled embryonal rhabdomyosarcoma for
Early this year, cc-TDI launched the Myoepithelial Carcinoma Biology & EWSR1 Orphan Cancers Drug Discovery Research Program. This project, spearheaded by Michael Casaus and Naomi
We did it! cc-TDI has developed the world’s first genetically-engineered mice that contain the Pax7-Foxo1 gene fusion found in some forms of alveolar rhabdomyosarcoma. Typically,
Two months ago cc-TDI announced the exciting launch of our Expansion Campaign and the big news that early in 2023 cc-TDI will relocate to our
Alyssa recently completed a 6-week research internship at cc-TDI. In her own words, here is a summary of her experience. My time at cc-TDI has
At the end of 2022, the Children’s Cancer Therapy Development Institute (cc-TDI) will relocate to a newly expanded, high-tech laboratory in nearby Hillsboro, Oregon; increasing
After my brother Shane passed in 2015, I asked my parents if we could hold a lemonade stand down by the shore in honor of
Groundbreaking Epithelioid Sarcoma Study Reveals Clues to Treatment Discovery Beaverton, OR – Children’sCancer Therapy Development Institute (cc-TDI) Biomedical Engineer Samuel Rasmussen led a study with
Executive Director, Children’s Cancer Therapy Development Institute (Beaverton, OR) Join the team of “rebel scientists” at cc-TDI who are pushing the boundaries of scientific innovation
The Children’s Cancer Therapy Development Institute (cc-TDI) was awarded $100,000 in support of Diffuse Intrinsic Pontine Glioma (DIPG) research by The Lyla Nsouli Foundation for
My name is Amy, and I am the proud mom of two amazing boys, Avery and Evan. Our son Avery has battled embryonal rhabdomyosarcoma for
Early this year, cc-TDI launched the Myoepithelial Carcinoma Biology & EWSR1 Orphan Cancers Drug Discovery Research Program. This project, spearheaded by Michael Casaus and Naomi
We did it! cc-TDI has developed the world’s first genetically-engineered mice that contain the Pax7-Foxo1 gene fusion found in some forms of alveolar rhabdomyosarcoma. Typically,
Two months ago cc-TDI announced the exciting launch of our Expansion Campaign and the big news that early in 2023 cc-TDI will relocate to our
Alyssa recently completed a 6-week research internship at cc-TDI. In her own words, here is a summary of her experience. My time at cc-TDI has
At the end of 2022, the Children’s Cancer Therapy Development Institute (cc-TDI) will relocate to a newly expanded, high-tech laboratory in nearby Hillsboro, Oregon; increasing
After my brother Shane passed in 2015, I asked my parents if we could hold a lemonade stand down by the shore in honor of
Groundbreaking Epithelioid Sarcoma Study Reveals Clues to Treatment Discovery Beaverton, OR – Children’sCancer Therapy Development Institute (cc-TDI) Biomedical Engineer Samuel Rasmussen led a study with
EIN: 46-5759569
cc-TDI is a qualified 501(c)(3) charitable organization registered with the IRS
(consult with a CPA regarding specific tax implications)
Copyright 2023 – Children’s Cancer Therapy Development Institute